About
A company profile built around trust, expertise and steady growth
The about section presents company background, timeline, expertise, credentials and international collaboration.
Company overview
HEER Medical supports clinical institutions and partners with coordinated service and medical innovation capabilities.
The company has continued to invest in structured service delivery, professional collaboration and scalable digital organization.
This new website turns a traditional corporate presentation into a future-ready content foundation for multiple digital ends.
Long-term engagement in medical service and technology related fields
Supporting key regional institutions and collaboration scenarios
Research, institutional and regional partnership approaches
Corporate Culture
Vision
Bringing AI-powered products to grassroots healthcare, solving industry pain points, and building a full-link closed-loop service ecosystem!
Core Values
Integrity & Pragmatism Innovation & Enterprise
Corporate Culture
HEER stands for “Health, Exactness, Excellence and Reputation,” representing HEER’s aspirations and conveying its cultural philosophy—dedicated to women’s health care and striving to be an industry leader. With the call of “Caring for your health, cherishing your family,” the company inspires its people and focuses on employee growth.
Company timeline
Key milestones from 2006 to today, showing how HEER Medical has grown in technology, service and partnerships.
Pioneering Start
HEER Medical was founded, embarking on a journey of exploration in pathology diagnostics.
Breakthrough Growth
In June 2015, HEER Medical completed merger and restructuring with New Open Source Group.
Forge Ahead
In August 2017, built a new office building along with a Class 300,000 cleanroom production facility and warehousing environment.
Comprehensive Layout
Launched HPV E6/E7 detection projects and built the upstream-downstream tumor screening chain. Actively supported government “two cancers” screening programs with charitable funding.
Platform Building
Continued development of IHC stainers, dual-stain assays, Ki67/p16 antibodies and AI-assisted diagnostic systems, establishing immuno and smart pathology platforms.